Mixed endocrine tumors;Les tumeurs mixtes endocrines

Annales de Pathologie

Volumn 25, Issue 6, 2005, Pages 511-528

  Hervieu, Valérie ^a   Scoazec, Jean Yves ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Amphicrine tumors; Collision tumors; Composite tumors; Immunohistochemistry; Mixed tumors

Indexed keywords

BIOLOGICAL MARKER; CHROMOGRANIN A; SYNAPTOPHYSIN;

ADENOCARCINOMA; CLINICAL FEATURE; CYTOPATHOLOGY; DIGESTIVE SYSTEM; DISEASE CLASSIFICATION; ENDOCRINE CELL; ENDOCRINE TUMOR; EPITHELIUM TUMOR; HUMAN; IMMUNOCYTOCHEMISTRY; MIXED TUMOR; PANCREAS; REVIEW; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION;

EID: 33646368698     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0242-6498(05)86164-4     Document Type: Short Survey

References (128)

1. Solcia E, Klöppel G, Sobin LH. Histological typing of endocrine tumours. Springer Verlag, New York ; 2000.
2. Lewin K. Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 1987 ; 11 Suppl 1 : 71-86.
3. Capella C, La Rosa S, Uccella S, Billo P, Comaggia M. Mixed endocrine-exocrine tumors of the gastrointestinal tract. Semin Diagn Pathol 2000 ; 17 : 91-103.
4. Wang C, Zhao P, Shao Y, Liu F, Lin D, Bao H. Clinical and pathological analysis of collision carcinoma: report of 7 patients. World J Gastroenterol 2002 ; 38 : 838-9.
5. Maiorana A, Fante R, Maria Cesinaro A, Adriana Fano R. Synchronous occurrence of epithelial and stromal tumors in the stomach: a report of 6 cases. Arch Pathol Lab Med 2000 ; 124 : 682-6.
6. Andea AA, Lucas C, Cheng JD, Adsay NV. Synchronous occurrence of epithelial and stromal tumors in the stomach. Arch Pathol Lab Med 2001 ; 125 : 318-9.
7. Bonkhoff H, Stein U, Remberger K. Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 1994 ; 25 : 42-6.
8. Novello P, Duvillard P, Grandjouan S, Elias D, Rougier P, Bognel C et al. Carcinomas of the colon with multidirectional differentiation. Report of two cases and review of the literature. Dig Dis Sci 1995 ; 40 : 100-6.
9. Kanamoto A, Nakanishi Y, Ochiai A, Shimoda T, Yamaguchi H, Tachimori Y et al. A case of small polypoid esophageal carcinoma with multidirectional differentiation, including neuroendocrine, squamous, ciliated glandular, and sarcomatous components. Arch Pathol Lab Med 2000 ; 124 : 1685-7.
10. Chejfec G, Capella C, Solcia E, Jao W, Gould VE. Amphicrine cells, dysplasias, and neoplasias. Cancer 1985 ; 56 : 2683-90.
11. Mandoky L. Amphicrine tumor. Pathol Oncol Res 1999 ; 5 : 239-44.
12. Graham AR, Payne CM, Nagle RB, Angel E. The role of immunohistochemistry, electron microscopy, and ultrastructural cytochemistry in the diagnosis of mixed carcinoma-neuroendocrine neoplasms. Pathol Res Pract 1987 ; 182 : 23-33.
13. Hayashi H, Ooi A, Nakanishi I. Biological and clinicopathological significance of endocrine differentiation of gastric adenocarcinoma evaluated by double immunohistochemical labeling for chromogranin A and bromodeoxyuridine. Jpn J Clin Oncol 1990 ; 20 : 339-48.
14. Chen BF, Yin H. Neuro-endocrine type of gastric carcinoma. Immunohistochemical and electron microscopic studies of 100 cases. Chin Med J 1990 ; 103 : 561-4.
15. Hamilton K, Chiappori A, Olson S, Sawyers J, Johnson D, Washington K. Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma. Mod Pathol 2000 ; 13 : 475-81.
16. Yao GY, Zhou JL, Lai MD, Chen XQ, Chen PH. Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases. World J Gastroenterol 2003 ; 9 : 858-61.
17. Grabowski P, Schindler I, Anagnostopoulos I, Foss HD, Riecken EO, Mansmann U et al. Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer. Eur J Gastroenterol Hepatol 2001 ; 13 : 405-11.
18. Naritomi K, Futami K, Arima S, Iwashita A. Malignant potential regarding mucin phenotypes and endocrine cell differentiation in gastric adenocarcinoma. Anticancer Res 2003 ; 23 : 4411-22.
19. Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A et al. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Cancer 2003 ; 97 : 2487-97.
20. Rutishauser U, Acheson A, Hall AK, Mann DM, Sunshine J. The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 1988 ; 240 : 53-7.
21. Johnson CP, Fujimoto I, Rutishauser U, Leckband DE. Direct evidence that neural cell adhesion molecule (NCAM) polysialylation increases intermembrane repulsion and abrogates adhesion. J Biol Chem 2005 ; 280 : 137-45.
22. Klappenbach RS, Kurman RJ, Sinclair CF, James LP. Composite carcinoma-carcinoid tumors of the gastrointestinal tract. A morphologic, histochemical, and immunocytochemical study. Am J Clin Pathol 1985 ; 84 : 137-43.
23. Levendoglu H, Cox CA, Nadimpalli V. Composite (adenocarcinoid) tumors of the gastrointestinal tract. Dig Dis Sci 1990 ; 35 : 519-25.
24. Ugras S, Akpolat N, Er M, Yalcynkaya I, Karaayvaz M. Primary composite tumour with bipartite differentiation of the esophagus. Acta Chir Belg 2000 ; 100 : 39-43.
25. Wilson CI, Summerall J, Willis I, Lubin J, Inchausti BC. Esophageal collision tumor (Large cell neuroendocrine carcinoma and papillary carcinoma) arising in a Barrett esophagus. Arch Pathol Lab Med 2000 ; 124 : 411-5.
26. Gonzalez LM, Sanz-Esponera J, Saez C, Alvarez T, Sierra E, Sanz-Ortega J. Case report: esophageal collision tumor (oat cell carcinoma and adenocarcinoma) in Barrett's esophagus: immunohistochemical, electron microscopy and LOH analysis. Histol Histopathol 2003 ; 18 : 1-5.
27. Corsi A, Bosman C. Adenocarcinoma and atypical carcinoid: morphological study of a gastric collision-type tumour in the carcinoma-carcinoid spectrum. Ital J Gastroenterol 1995 ; 27 : 303-8.
28. Rassidakis GZ, Delladetsima JK, Letsos SP, Polyzos A, Yannopoulos A. Hepatoid adenocarcinoma of the stomach with extensive neuroendocrine differentiation and a coexisting carcinoid tumour. Histopathology 1998 ; 33 : 186-8.
29. Ulich TR, Kollin M, Lewin KJ. Composite gastric carcinoma. Report of a tumor of the carcinoma-carcinoid spectrum. Arch Pathol Lab Med 1988 ; 112 : 91-3.
30. Blumenfeld W, Chandhoke DK, Sagerman P, Turi GK. Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study. Arch Pathol Lab Med 1996 ; 120 : 478-81.
31. Alameda F, Curell R. Carcinoid tumors with focal mucin production. Appl Pathol 1989 ; 7 : 361-6.
32. Ito H, Ito M, Tahara E. Minute carcinoid arising in gastric tubular adenoma. Histopathology 1989 ; 15 : 96-9.
33. De Marco L, Carlinfante G, Botticelli L, Di Maira PV, Putrino I, Cavazza A. [Mixed neoplasia of the stomach: description of a case of tubular adenoma combined with carcinoid]. Pathologica 2003 ; 95 : 214-6.
34. Rayhan N, Sano T, Qian ZR, Obari AK, Hirokawa M. Histological and immunohistochemical study of composite neuroendocrine-exocrine carcinomas of the stomach. J Med Invest 2005 ; 52 : 191-202.
35. Jain D, Eslami-Varzaneh F, Takano AM, Ayer U, Umashankar R, Muller R et al. Composite Glandular and Endocrine Tumors of the Stomach With Pancreatic Acinar Differentiation. Am J Surg Pathol 2005 ; 29 : 1524-9.
36. Gardner HA, Matthews J, Ciano PS. A signet-ring cell carcinoma of the ampulla of Vater. Arch Pathol Lab Med 1990 ; 114 : 1071-2.
37. Barnhill M, Hess E, Guccion JG, Nam LH, Bass BL, Patterson RH. Tripartite differentiation in a carcinoma of the duodenum. Cancer 1994 ; 73 : 266-72.
38. Griffiths DF, Jasani B, Newman GR, Williams ED, Williams GT. Glandular duodenal carcinoid - a somatostatin rich tumour with neuroendocrine associations. J Clin Pathol 1984 ; 37 : 163-9.
39. Jones MA, Griffith LM, West AB. Adenocarcinoid tumor of the periampullary region: a novel duodenal neoplasm presenting as biliary tract obstruction. Hum Pathol 1989 ; 20 : 198-200.
40. Moncur JT, Lacy BE, Longnecker DS. Mixed acinar-endocrine carcinoma arising in the ampulla of Vater. Hum Pathol 2002 ; 33 : 449-51.
41. Lundqvist M, Wilander E. Exocrine and endocrine cell differentiation in small intestinal adenocarcinomas. Acta Pathol Microbiol Immunol Scand [A] 1983 ; 91 : 469-74.
42. Varghese NM, Zaitoun AM, Thomas SM, Senapati A, Theodossi A. Composite glandular-carcinoid tumour of the terminal ileum. J Clin Pathol 1994 ; 47 : 427-9.
43. Ruby SG. Protocol for the examination of specimens from patients with carcinomas of the small intestine, including those with focal endocrine differentiation, exclusive of carcinoid tumors, lymphomas, and stromal tumors (sarcomas): a basis for checklists. Cancer Committee, American college of Pathologists. Arch Pathol Lab Med 2000 ; 12 : 46-50.
44. Burke AP, Sobin LH, Federspiel BH, Shekitka KM. Appendiceal carcinoids: correlation of histology and immunohistochemistry. Mod Pathol 1989 ; 2 : 630-7.
45. Burke AP, Sobin LH, Federspiel BH, Shekitka KM, Helwig EB. Goblet cell carcinoids and related tumors of the vermiform appendix. Am J Clin Pathol 1990 ; 94 : 27-35.
46. Carr NJ, Sobin LH. Neuroendocrine tumors of the appendix. Semin Diagn Pathol 2004 ; 21 : 108-19.
47. Isaacson P. Crypt cell carcinoma of the appendix (so-called adenocarcinoid tumor). Am J Surg Pathol 1981 ; 5 : 213-24.
48. Rossi G, Bertolini F, Sartori G, Bigiani N, Cavazza A, Foroni M et al. Primary mixed adenocarcinoma and small cell carcinoma of the appendix: a clinicopathologic, immunohistochemical, and molecular study of a hitherto unreported tumor. Am J Surg Pathol 2004 ; 28 : 1233-9.
49. Iwashita A, Watanabe H, Enjoji M. Argyrophil and argentaffin cells in adenomas of the colon and rectum. Fukuoka Igaku Zasshi 1989 ; 80 : 114-24.
50. Lapertosa G, Baracchini P, Delucchi F. Prevalence and prognostic significance of endocrine cells in colorectal adenocarcinomas. Pathologica 1994 ; 86 : 170-3.
51. El-Salhy M, Mahdavi J, Norrgard O. Colonic endocrine cells in patients with carcinoma of the colon. Eur J Gastroenterol Hepatol 1998 ; 10 : 517-22.
52. Foley EF, Gaffey MJ, Frierson HF Jr. The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon. Arch Pathol Lab Med 1998 ; 122 : 912-4.
53. Atasoy P, Bozdogan O, Ozturk S, Ensari A. Bcl2 expression and its correlation with neuroendocrine differentiation in colon carcinomas. Tumori 2004 ; 90 : 233-8.
54. Romeo R, Pellitteri R, Mazzone V, Marcello MF. Chromogranin A expression in human colonic adenocarcinoma. Ital J Anat Embryol 2002 ; 107 : 177-83.
55. Arai T, Kino I. Histochemical and ultrastructural analyses of glandular differentiation in typical carcinoid tumor of the hindgut. Pathol Int 1994 ; 44 : 49-56.
56. Lyda MH, Fenoglio-Preiser CM. Adenoma-carcinoid tumors of the colon. Arch Pathol Lab Med 1998 ; 122 : 262-5.
57. Jiao YF, Nakamura S, Arai T, Sugai T, Uesugi N, Habano W et al. Adenoma, adenocarcinoma and mixed carcinoid-adenocarcinoma arising in a small lesion of the colon. Pathol Int 2003 ; 53 : 457-62.
58. Anagnostopoulos GK, Arvanitidis D, Sakorafas G, Pavlakis G, Kolilekas L, Arkoumani E et al. Combined carcinoid-adenocarcinoma tumour of the anal canal. Scand J Gastroenterol 2004 ; 39 : 198-200.
59. Barsky SH, Linnoila I, Triche TJ, Costa J. Hepatocellular carcinoma with carcinoid features. Hum Pathol 1984 ; 15 : 892-4.
60. Artopoulos JG, Destuni C. Primary mixed hepatocellular carcinoma with carcinoid characteristics. A case report. Hepatogastroenterology 1994 ; 41 : 442-4.
61. Hidaka H, Kuwao S, Kokubu S, Yanagimoto K, Satomichi A, Takada M et al. Mixed carcinoid-adenocarcinoma of the liver. Intern Med 2000 ; 39 : 910-3.
62. Yamaguchi R, Nakashima O, Ogata T, Hanada K, Kumabe T, Kojiro M. Hepatocellular carcinoma with an unusual neuroendocrine component. Pathol Int 2004 ; 54 : 861-5.
63. Edakuni G, Sasatomi E, Satoh T, Tokunaga O, Miyazaki K. Composite glandular-endocrine cell carcinoma of the common bile duct. Pathol Int 2001 ; 51 : 487-90.
64. O'Hara BJ, McCue PA, Miettinen M. Bile duct adenomas with endocrine component. Immunohistochemical study and comparison with conventional bile duct adenomas. Am J Surg Pathol 1992 ; 16 : 21-5.
65. Ohmori T, Furuya K, Okada K, Tabei R, Tao S. Adenoendocrine cell carcinoma of the gallbladder: a histochemical and immunohistochemical study. Acta Pathol Jpn 1993 ; 43 : 268-74.
66. Yamamoto J, Abe Y, Nishihara K, Katsumoto F, Takeda S, Abe R et al. Composite glandular-neuroendocrine carcinoma of the hilar bile duct: report of a case. Surg Today ; 28 : 758-62.
67. Eriguchi N, Aoyagi S, Noritomi T, Imamura M, Sato S, Fujiki K et al. Adeno-endocrine cell carcinoma of the gallbladder. J Hepatobiliary Pancreat Surg 2003 ; 7 : 97-101.
68. Iida Y, Tsutsumi Y. Small cell (endocrine cell) carcinoma of the gallbladder with squamous and adenocarcinomatous components. Acta Pathol Jpn 1992 ; 42 : 119-25.
69. Kloppel G. Mixed exocrine-endocrine tumors of the pancreas. Semin Diagn Pathol 2000 ; 17 : 104-8.
70. Kamisawa T, Fukayama M, Tabata I, Isawa T, Tsuruta K, Okamoto A et al. Neuroendocrine differentiation in pancreatic duct carcinoma special emphasis on duct-endocrine cell carcinoma of the pancreas. Pathol Res Pract 1996 ; 192 : 901-8.
71. Sakaki M, Sano T, Hirokawa M, Takahashi M, Kiyoku H. Immunohistochemical study of endocrine cells in ductal adenocarcinoma of the pancreas. Virchows Arch 2002 ; 441 : 249-55.
72. Deshpande V, Selig MK, Nielsen GP, Fernandez-del Castillo C, Lauwers GY. Ductulo-insular pancreatic endocrine neoplasms: clinicopathologic analysis of a unique subtype of pancreatic endocrine neoplasms. Am J Surg Pathol 2003 ; 27 : 461-8.
73. van Eeden S, de Leng WW, Offerhaus GJ, Morsink FH, Weterman MA, de Krijger RR et al. Ductuloinsular tumors of the pancreas: endocrine tumors with entrapped nonneoplastic ductules. Am J Surg Pathol 2004; 28: 813-20.
74. Chatelain D, Parc Y, Christin-Maitre S, Parc R, Flejou JF. Mixed ductal-pancreatic polypeptide-cell carcinoma of the pancreas. Histopathology 2002 ; 41 : 122-6.
75. Ohike N, Jurgensen A, Pipeleers-Marichal M, Kloppel G. Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells. Virchows Arch 2003 ; 442 : 258-65.
76. Klimstra DS, Rosai J, Heffess CS. Mixed acinar-endocrine carcinomas of the pancreas. Am J Surg Pathol 1994 ; 18 : 765-78.
77. Compton CC. Protocol for the examination of specimens from patients with endocrine tumors of the pancreas, including those with mixed endocrine and acinar cell differentiation: a basis for checklists. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 2000 ; 124 : 30-6.
78. Ohike N, Kosmahl M, Kloppel G. Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch 2004 ; 445 : 231-5.
79. Schron DS, Mendelsohn G. Pancreatic carcinoma with duct, endocrine, and acinar differentiation. A histologic, immunocytochemical, and ultrastructural study. Cancer 1984 ; 54 : 1766-70.
80. Ordonez NG, Balsaver AM, Mackay B. Mucinous islet cell (amphicrine) carcinoma of the pancreas associated with watery diarrhea and hypokalemia syndrome. Hum Pathol 1988 ; 19 : 1458-61.
81. Sylla A, Hervieu V, Lombard-Bohas C, Taniere P, Elbaz N, Scoazec JY. Amphicrine carcinoma of the pancreas. Report of two cases. Ann Pathol 2003 ; 23 : 424-9.
82. Ruck P, Pfisterer EM, Kaiserling E. Carcinoid tumour of the middle ear. A morphological and immunohistochemical study with comments on histogenesis and differential diagnosis. Pathol Res Pract 1989 ; 185 : 496-503.
83. Azzoni C, Bonato M, D'Adda T, Usellini L, Piazza F, Gandolfi A et al. Well-differentiated endocrine tumours of the middle ear and of the hindgut have immunocytochemical and ultrastructural features in common. Virchows Arch 1995 ; 426 : 411-8.
84. Wassef M, Kanavaros P, Polivka M, Nemeth J, Monteil JP, Frachet B et al. Middle ear adenoma. A tumor displaying mucinous and neuroendocrine differentiation. Am J Surg Pathol 1989 ; 13 : 838-47.
85. Davies JE, Semeraro D, Knight LC, Griffiths GJ. Middle ear neoplasms showing adenomatous and neuroendocrine components. J Laryngol Otol 1989 ; 103 : 404-7.
86. Faverly DR, Manni JJ, Smedts F, Verhofstad AA, van Haelst UJ. Adeno-carcinoid or amphicrine tumors of the middle ear - a new entity? Pathol Res Pract 1992 ; 188 : 162-71.
87. Ketabchi S, Massi D, Franchi A, Vannucchi P, Santucci M. Middle ear adenoma is an amphicrine tumor: why call it adenoma? Ultrastruct Pathol 2001 ; 25 : 73-8.
88. Muller KM, Fisseler-Eckhoff A. What's new in lung tumor heterogeneity? Pathol Res Pract 1988 ; 184 : 108-15.
89. Jiang SX, Kameya T, Sato Y, Yanase N, Yoshimura H, Kodama T. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Am J Pathol 1996 ; 148 : 837-46.
90. Chetty R. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells. Pathology 2000 ; 32 : 209-12.
91. Huang J, Behrens C, Wistuba II, Gazdar AF, Jagirdar J. Clonality of combined tumors. Arch Pathol Lab Med 2002 ; 126 : 437-41.
92. Murase T, Takino H, Shimizu S, Inagaki H, Tateyama H, Takahashi E et al. Clonality analysis of different histological components in combined small cell and non-small cell carcinoma of the lung. Hum Pathol 2003 ; 34 : 1178-84.
93. Cavazza A, Toffanetti R, Ferrari G, Piana S, Putrino I, Gardini G. Combined neoplasia of the lung: description of a case of adenocarcinoma mixed with typical carcinoid. Pathologica 2001 ; 93 : 216-20.
94. Hiroshima K, Iyoda A, Shibuya K, Toyozaki T, Haga Y, Fujisawa T et al. Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung. Ann Thorac Surg 2002 ; 73 : 1732-5.
95. Yazawa T, Ishii H, Ito T, Yoshiike Y, Ogawa N, Okudela K et al. Colliding primary lung cancers of adenosquamous carcinoma and large cell neuroendocrine carcinoma. Pathol Int 2003 ; 53 : 58-65.
96. di Sant' Agnese PA. Divergent neuroendocrine differentiation in prostatic carcinoma. Semin Diagn Pathol 2000 ; 17 : 149-61.
97. Makretsov N, Gilks CB, Coldman AJ, Hayes M, Huntsman D. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol 2003 ; 34 : 1001-8.
98. Capella C, Usellini L, Papotti M, Macri L, Finzi G, Eusebi V et al. Ultrastructural features of neuroendocrine differentiated carcinomas of the breast. Ultrastruct Pathol 1990 ; 14 : 321-34.
99. Capella C, Eusebi V, Mann B, Azzopardi JG. Endocrine differentiation in mucoid carcinoma of the breast. Histopathology 1980 ; 4 : 613-30.
100. Azzopardi JG. Mucoid carcinomas of breast. Typing: exocrine, endocrine and amphicrine. Histopathology 1987 ; 11 : 668.
101. Coyne JD, Dervan PA, Barr L, Baildam AD. Mixed apocrine/endocrine ductal carcinoma in situ of the breast coexistent with lobular carcinoma in situ. J Clin Pathol 2001 ; 54 : 70-3.
102. Berger G, Frappart L, Guillaud M, Mallet-Guy Y, Patricot LM, Feroldi J. Amphicrine, mucoid and argyrophile tumors of the breast. Histochemical and ultrastructural study of 2 cases. Ann Pathol 1982 ; 2 : 213-22.
103. Eyden B, Banerjee SS, Nesland JM. Amphicrine carcinoma of breast with giant granules: an immunohistochemical, histochemical and ultrastructural study. J Submicrosc Cytol Pathol 2002 ; 34 : 27-36.
104. Husain AN, Gattuso P, Abraham K, Castelli MJ. Synchronous adenocarcinoma and carcinoid of the uterine cervix: immunohistochemical study of a case and review of literature. Gynecol Oncol 1989 ; 33 : 125-8.
105. Bung JT, Liu HS, Yang YF, Tyan HS, Yin CS. Neuroendocrine carcinomas associated with squamous cell carcinomas of the uterine cervix: light and electron microscopic observations in two cases. Zhonghua Yi Xue Za Zhi (Talpei) 1991 ; 48 : 469-76.
106. Hammar SP, Insalaco SJ, Lee RB, Bockus DE, Remington FL, Yu A. Amphicrine carcinoma of the uterine cervix. Am J Clin Pathol 1992 ; 97 : 516-22.
107. Cardosi RJ, Reedy MB, Van Nagell JR, Spires SE. Neuroendocrine signet ring cell adenocarcinoma of the endocervix. Int J Gynecol Cancer 1999 ; 9 : 433-7.
108. Fukushima M, Twiggs LB, Okagaki T. Mixed intestinal adenocarcinoma-argentaffin carcinoma of the vagina. Gynecol Oncol 1986 ; 23 : 387-94.
109. Hidvegi J, Zsolnai B, Szinay G. Amphicrine tumor of the vulva. Pathol Res Pract 1988 ; 183 : 505-11.
110. Eichhorn JH, Lawrence WD, Young RH, Scully RE. Ovarian neuroendocrine carcinomas of non-small-cell type associated with surface epithelial adenocarcinomas. A study of five cases and review of the literature. Int J Gynecol Pathol 1996 ; 15 : 303-14.
111. Ngan HY, Collins RJ, Wong LC, Chan SY, Ma HK. The value of tumor markers in a mixed tumor, mucinous and neuroendocrine carcinoma of the ovary. Gynecol Oncol 1989 ; 35 : 272-4.
112. Baker PM, Oliva E, Young RH, Talerman A, Scully RE. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases. Am J Surg Pathol 2001 ; 25 : 557-68.
113. Matias-Guiu X, Forteza J, Prat J. Mixed strumal and mucinous carcinoid tumor of the ovary. Int J Gynecol Pathol 1995 ; 14 : 179-83.
114. Foschini MP, Eusebi V. Divergent differentiation in endocrine and nonendocrine tumors of the skin. Semin Diagn Pathol 2000 ; 17 : 162-8.
115. George E, Swanson PE, Wick MR. Neuroendocrine differentiation in basal cell carcinoma. An immunohistochemical study. Am J Dermatopathol 1989 ; 11 : 131-5.
116. Mendelsohn G, Maksem JA. Divergent differentiation in neoplasms. Pathologic, biologic, and clinical considerations. Pathol Annu 1986 ; 21 : 91-119.
117. Kikuyama S, Orikasa H, Oyama R, Yamazaki K. A unique early gastric tubular adenocarcinoma arising from a pre-existent carcinoid tumor in a patient with a more than 20-year history of type A gastritis: an immunohistochemical and ultrastructural study. J Submicrosc Cytol Pathol 2002 ; 34 : 109-14.
118. Kim KM, Kim MJ, Cho BK, Choi SW, Rhyu MG. Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas. Virchows Arch 2002 ; 440 : 85-93.
119. Milne AN, Carvalho R, van Rees BP, van Lanschot JJ, Offerhaus GJ, Weterman MA. Do collision tumors of the gastroesophageal junction exist? A molecular analysis. Am J Surg Pathol 2004 ; 28 : 1492-8.
120. Ogawa A, Sugo H, Takamori S, Kojima K, Fukasawa M, Beppu T et al. Double cancers in the common bile duct: molecular genetic findings with an analysis of LOH. J Hepatobiliary Pancreat Surg 2001 ; 8 : 374-8.
121. Lee EJ, Park SM, Maeng L, Lee A, Kim KM. Composite glandular-endocrine cell carcinomas of the stomach: clinicopathologic and methylation study. APMIS 2005 ; 113 : 569-76.
122. Vortmeyer AO, Lubensky IA, Merino MJ, Wang CY, Pham T, Furth EE et al. Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst 1997 ; 89 : 1448-53.
123. Ubiali A, Benetti A, Papotti M, Villanacci V, Rindi G. Genetic alterations in poorly differentiated endocrine colon carcinomas developing in tubulo-villous adenomas: a report of two cases. Virchows Arch 2001 ; 439 : 776-81.
124. Van Eeden S, Nederlof PM, Taal BG, Offerhaus GJ, Van Velthuysen ML. A tumour with a neuroendocrine and papillary serous component: two or a pair? J Clin Pathol 2002 ; 55 : 710-4.
125. Furlan D, Cerutti R, Genasetti A, Pelosi G, Uccella S, La Rosa S et al. Microallelotyping defines the monoclonal or the polyclonal origin of mixed and collision endocrine-exocrine tumors of the gut. Lab Invest 2003 ; 83 : 963-71.
126. Christophe J. Pancreatic tumoral cell line AR42J: an amphicrine model. Am J Physiol 1994 ; 266 : G963-71.
127. Rosewicz S, Ahnert-Hilger G, Haller H, Riecken EO, Wiedenmann B. Rat pancreatic AR42J cells. Amphicrine cells as an in vitro model to study peptide hormone receptor regulation. Ann N Y Acad Sci 1994 ; 733 : 407-15.
128. de Bruine AP, Dinjens WN, Pijls MM, vd Linden EP, Rousch MJ, Moerkerk PT et al. NCI-H716 cells as a model for endocrine differentiation in colorectal cancer. Virchows Arch B Cell Pathol 1992 ; 62 : 311-20.